KIM-1 and cystatin C were analyzed as biomarkers for detecting subclinical acute kidney injury (AKI) before serum creatinine levels rise, helping prevent irreversible kidney damage [14,15]. This evidence concerns the gene HAVCR1 and Nephropathy.